On the whole, lean individuals had lower prevalence for these conditions than people with overweight or obesity.

A recent study also found that having a higher body mass index was associated with a higher risk of fatty liver disease.

The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.

In these women, higher testosterone ramped up the likelihood of abdominal fat buildup.

Twelve states have an adult obesity prevalence of 35% or more.

The experimental drug led to significant reduction in body weight but was accompanied by nausea and vomiting.

A daily dose of the growth factor analogue administered over 24 weeks also aided in NASH resolution.

A look at 3 forms of fatty liver disease: Non-Alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis

Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes.

Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.